NN

NewAmsterdam Pharma Company NV

NAMS

NASDAQHealth Care

Income Statement

Total Revenue$107.06M

Operating Income$0

EBITDA$0

EBIT$-85.27M

Pre-tax Income$-159.11M

Net Income$-159.11M

Balance Sheet

Cash Equivalent$383.5M

Total Debt$87K

Book Value$757.5

Book Value Per Share7.01

Key Ratios

Return on Equity (ROE)-31.89%

Return on Assets (ROA)-27.94%

Return on Invested Capital (ROI)-31.89%

Net Profit Margin-530.25%

Current Ratio8.08

Quick Ratio8.00

Long-Term Debt / Equitynull